![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Lack of Effect of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir
Disoproxil Fumarate on Glomerular Filtration Rate in HIV-Infected Patients
|
|
|
Reported by Jules Levin
18th International Workshop on Clinical Pharmacology of Antiviral Therapy, June 14-16, 2017, Chicago, IL
Joseph M. Custodio, Sophia R. Majeed, Hui Wang, Andrew Plummer, Kah Hiing J. Ling, Martin Rhee, Moupali Das, Brian P. Kearney
Gilead Sciences, Inc., Foster City, California, USA
![0621171](../images/062117/062117-5/0621171.gif)
![0621172](../images/062117/062117-5/0621172.gif)
![0621173](../images/062117/062117-5/0621173.gif)
![0621174](../images/062117/062117-5/0621174.gif)
![0621175](../images/062117/062117-5/0621175.gif)
![0621176](../images/062117/062117-5/0621176.gif)
![0621177](../images/062117/062117-5/0621177.gif)
![0621178](../images/062117/062117-5/0621178.gif)
References
1. Stribild [package insert]. Foster City, CA: Gilead Sciences, Inc., 9/2016; 2. Lepist I, et al. ICAAC 2011, poster A1-1724; 3. German P, et al. J Acquir Immune Defic Syndr 2012;61:32-40; 4. Ramanathan S, et al. CROI 2013, poster 524; 5. Atripla [package
insert]. Foster City, CA: Gilead Sciences, Inc., 4/2017; 6. Klein CE, et al. J Clin Pharmacol 2008;48:553-62; 7. Truvada [package insert]. Foster City, CA: Gilead Sciences, Inc., 4/2017.
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|